4.7 Letter

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies

Journal

CELL DISCOVERY
Volume 7, Issue 1, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41421-021-00347-1

Keywords

-

Categories

Funding

  1. National Science Fund for Distinguished Young Scholars [82025022]
  2. National Natural Science Foundation of China [82002140]
  3. Guangdong Basic and Applied Basic Research Foundation [2021B1515020034, 2019A1515011197, 2021A1515011009, 2020A1515110656]
  4. Shenzhen Science and Technology Program [RCYX20200714114700046, JSGG20200207155251653, JSGG20200807171401008, KQTD20200909113758004, JCYJ20190809115617365, JCYJ20180228162229889]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available